Results 131 to 140 of about 1,484,561 (230)

Identification of Urokinase Plasminogen Activator Receptor (uPAR)-Binding Peptides Using Phage Display: Strategy and Downstream Validation. [PDF]

Cancers (Basel)
Sloth AB, Dawoodi IM, Treiberg T, Sinkjaer AW, Andersen IV, Andersen AO, Bøgestad ECS, Rossing M, Stavnsbjerg C, Bakhshinejad B, Kjaer A.   +10 more
europepmc   +1 more source

Urokinase plasminogen activator receptor attenuates allergen-induced eosinophil migration and airway hyperresponsiveness. [PDF]

Am J Respir Cell Mol Biol
Whitehead GS, Nakano K, Wilkinson CL, Patterson AM, Upadhyay S, Massri AJ, Papas BN, Gruzdev A, Ray M, Nakano H, Cook DN.   +10 more
europepmc   +1 more source

Proteomics-Based Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated With Adverse Cardiovascular Outcomes in the General Population: Insights From the UK Biobank. [PDF]

J Am Heart Assoc
Sakr SM, Medina-Inojosa JR, Liu C, Chuckaree ID, Agusala V, Lodhi R, Mecklai Z, Owais M, Al Kasem M, Hritani W, Hasan M, Hayek S, Sun YV, Quyyumi AA.   +13 more
europepmc   +1 more source

Viral-specific induction of cellular and soluble urokinase plasminogen activator receptor (suPAR) expression. [PDF]

J Immunol
Sharma SB, Kumar K, Parchment N, Eggleston T, De Melo Jorge DM, Bamezai S, Wu W, Moore BB, Hayek SS, Hogan SP, Henke PK, Gallagher KA, Obi AT.   +12 more
europepmc   +1 more source

Evaluation of Serum Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels in Different Metabolic Obesity Phenotypes and Their Association with Inflammatory Cytokines: A Cross-Sectional Study. [PDF]

J Clin Med
Acet A, Ozdemir C, Solak H.
europepmc   +1 more source

Preclinical evaluation of a urokinase plasminogen activator receptor-targeted nanoprobe in rhesus monkeys

, 2015
Yushu Chen,1 Li Gong,2 Ning Gao,3 Jichun Liao,1 Jiayu Sun,1 Yuqing Wang,1 Lei Wang,1 Pengjin Zhu,1 Qing Fan,1 Yongqiang Andrew Wang,4 Wen Zeng,2 Hui Mao,3 Lily Yang,5 Fabao Gao11Molecular Imaging Center, Department of Radiology, West China Hospital ...
Wang YA, Yang L, Mao H, Fan Q, Zeng W, Gao F, Wang L, Liao J, Zhu P, Gao N, Chen Y, Gong L, Wang Y, Sun J   +13 more
core  

Molecular epidemiology of the expression of urokinase plasminogen activator receptor-associated protein (uPARAP) in mesenchymal malignancies. [PDF]

Transl Oncol
Wang CC, Barkholt P, Wozniak A, Vanleeuw U, Lee CJ, De Sutter L, De Cock L, Verbeeck K, Engelholm LH, Lynch C, Mumberg D, Schöffski P.   +11 more
europepmc   +1 more source

The inactivation of single-chain urokinase-type plasminogen activator by thrombin on cultured human endothelial cells

, 2000
Single-chain urokinase-type plasminogen activator (scu-PA) is cleaved by thrombin, resulting in an inactive molecule called thrombin-cleaved two-chain urokinase-type plasminogen activator (tcu-PA/T). There is no knowledge about cell-mediated inactivation
Collen, A., Rijken, D.C., Grimbergen, J.M., Jie, A.F.H., Braat, E.A.M.   +4 more
core  

Soluble urokinase plasminogen activator receptor and perioperative complications: a systematic review. [PDF]

BMC Anesthesiol
Gungor AB, Pennathur P, Guran HS, Chu W, Roshanov PS.   +4 more
europepmc   +1 more source

Soluble urokinase plasminogen activator receptor is a prognostic biomarker in decompensated cirrhosis. [PDF]

JHEP Rep
Lamatsch S, Hassan M, Kappert K, Berger H, Bai Q, Zhao Z, Walia N, De La Peña-Ramirez C, Mohr R, Demir M, Wang J, Artusa F, Sittner R, Andreola F, Veelken R, van Boemmel F, Schumacher J, Aehling N, Fischer J, Mookerjee R, Hu T, Berg T, Jalan R, Tacke F, Kumar P, Engelmann C.   +25 more
europepmc   +1 more source